| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |